Notice of Approval - Introduction of Midpoint Extended Life Order - Nasdaq CXC Limited

 
In accordance with the requirements set out in the Process for the Review and Approval of Rules and the Information Contained in Form 21-101F1 and the Exhibits Thereto (Exchange Protocol), on July 5th, 2019, the Commission approved significant changes to Form 21-101F1 for Nasdaq CXC Limited (Nasdaq Canada) reflecting the introduction of the Midpoint Extended Life Order (M-ELO) for the CXC Trading Book.

Nasdaq Canada’s Notice and Request for Comment on the proposed M-ELO was published on the Commission’s website and in the Commission’s Bulletin on June 6, 2019 at (2019) 42 OSCB 5155. No comment letters were received.

The M-ELO is expected to become effective in the fourth quarter of 2019.